Glipizide
Back to searchMolecule Structure
Scientific Name
Glipizide
Description of the Drug
Glipizide is a sulfonylurea medication used in Type 2 Diabetes to sensitize pancreatic beta cells and stimulate insulin release.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01067
http://www.drugbank.ca/drugs/DB01067
Brand Name(s)
Glibenese, Glipizide, Glucotrol, Glucotrol xl, Minodiab 2.5, Minodiab 5
Company Owner(s)
Watson Laboratories Inc, Pfizer Inc, Apotex Inc, Oxford Pharmaceuticals Llc, Bristol Myers Squibb Co, Par Pharmaceutical Inc, Zydus Pharmaceuticals Usa Inc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Sandoz Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sulfonylurea receptor 1, Kir6.2 | PROTEIN COMPLEX | BLOCKER | CHEMBL2096972 |
Clinical Trial(s)
Unichem Links
| Atlas | glipizide | |
| SureChEMBL | SCHEMBL17094 | |
| PharmGKB | PA449762 | |
| Human Metabolome Database | HMDB0015200 | |
| WDI | GLIPIZIDE | |
| DrugBank | DB01067 | |
| PubChem: Thomson Pharma | 14906210 | |
| PubChem | 3478 | |
| Mcule | MCULE-5142805548 | |
| LINCS | LSM-2251 | |
| Nikkaji | J20.336J | |
| BindingDB | 50012956 | |
| EPA CompTox Dashboard | DTXSID0040676 | |
| DrugCentral | 1301 | |
| Brenda | 88880 | |
| ChemicalBook | CB9185001 | |
| Guide to Pharmacology | 6821 | |
| GSRS | 7f560c62-af87-436c-9cf9-044010781f8d | |
| rxnorm | GLIPIZIDE | GLUCOTROL |
| ChEBI | 5384 | |
| NIH Clinical Collection | SAM002564210 | |
| ZINC | ZINC000000537795 |
